ARCHIVES

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Holden, Mayo, Hopkins Win Lymphoma SPOREs; Hutchinson Wins Prostate SPORE

October 4, 2002

In Brief: “Massive Reassessment” Of Centers Going On, Tim Talbot Believes; WHO Drops ICRB Service

December 9, 1977

NCI Moves Ahead To Find “Less-Hazardous” Cigarette

April 19, 1974

NIH Advisors Suggest Revamping Grant Application Review

June 14, 1996

Wynder Group Finds No Association Between Coffee, Pancreatic Cancer

August 19, 1983

Kyprolis Demonstrates Overall Response Following FDA Accelerated Approval

August 31, 2012